company
Alchymars ICM SM Private Limited
Industry: pharmaceutical
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_warning_letter · cgmp2026-05-21Alchymars ICM SM Private Limited — CGMP/Active Pharmaceutical Ingredient (API)/Adulterated (2026-05-21)
Frequently asked questions
- How many FDA warning letters has Alchymars ICM SM Private Limited received?
- Argus HQ has recorded 1 FDA warning letter for Alchymars ICM SM Private Limited.
- What FDA recalls has Alchymars ICM SM Private Limited issued?
- Argus HQ has not recorded an FDA recall tied to Alchymars ICM SM Private Limited in our current dataset.
- Is Alchymars ICM SM Private Limited FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 1 warning letter, 0 recalls, and 0 approval records for Alchymars ICM SM Private Limited. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.

